MedTrace Logo

PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel

NCT02855346 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-05-22

No results posted yet for this study

Summary

PK and Safety Study of Vaginal Ring Containing Dapivirine and Levonorgestrel

Conditions

  • HIV Prevention

Interventions

COMBINATION_PRODUCT

200 mg of DPV + 320 mg LNG

DPV VR, containing 200 mg DPV

COMBINATION_PRODUCT

200 mg of DPV

DPV-LNG VR, containing 200 mg of DPV + 320 mg LNG

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • International Partnership for Microbicides, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-03
Primary Completion
2017-08-18
Completion
2017-08-18
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02855346 on ClinicalTrials.gov